The objective of this webinar is to provide an overview of the research steps and methods involved in Pharmacy Practice Research. The webinar will start with a discussion on how to plan and execute a research idea, and the steps involved in this process. Research methods and approaches used in pharmacy practice research will be discussed. The webinar will provide insights on how to successfully write and publish a scientific paper from an editor’s perspective.

Finally a young researcher will share her ideas on her journey as a researcher – and what learnings she can share based on this.

• To introduce the relevance of qualitative methods in Pharmacy Practice Research
• To introduce the relevance of quantitative methods in Pharmacy Practice Research
• To give recommendations on publishing Pharmacy Practice Research
• To share learnings from a research journey, from novel researcher to established researcher

This session will examine the application of the concepts of the Health Belief Model (HBM) which is one of the first and still most commonly used frameworks or theories of health behavior. There has been successful application of the HBM in health and wellness programs, including immunization and chronic diseases management. As such, the application of HBM will be illustrated in a flu awareness campaign that targeted Lebanese University students. Examples of improving immunization rates and addressing patient perceptions in an ambulatory care setting in the U.S. will also be discussed.

Additionally, this session will discuss the application of the Continuing Professional Development (CPD) model to train pharmacists with the knowledge and skills in emergency preparedness and response, including mass vaccination.

Learning Objectives

1. Examine successful health initiatives using the HBM. (AK)
2. Describe two vaccination campaigns and programs in different populations to address vaccine hesitancy and improve vaccinate rates for flu and COVID-19 vaccines. (NM and SS)
3. Apply the Continuing professional development (CPD) model for pharmacists and student pharmacists to have structured approach for preparing health promotion programs, including COVID-19 mass vaccination.

In this Webinar we will discuss how various humanitarian organizations centred around pharmacy work have adapted to the COVID-19 pandemic

Learning Objectives

At the end of this webinar the participants will be able to:
1. Understand how humanitarian work can continue during pandemic times
2. Learn various examples of humanitarian work during the COVID-19 pandemic
3. Obtain new ideas and build networks within the humanitarian pharmacy field

The topics are based on three organisations discussing their work, challenges and innovations which they have encountered during the COVID-19 pandemic.

This webinar is open to everyone free of charge.

This event is organised by the Academy of Pharmaceutical Scientists (APS), the FIP Drug Delivery and Manufacturing Special Interest Group and the Board of Pharmaceutical Sciences of FIP. 

This online seminar will give an introduction to the MCS concept for the development of oral solid dosage forms (tablets and capsules). It will give case studies of its application throughout the drug development process in the areas of formulation design, process development, materials science and characterization of both API and drug product. There will be opportunity for discussion around the path forward for the MCS initiative, as well as barriers seen to future implementation.

Delegates will learn the principles of the MCS concept and how to apply it to both batch and continuous manufacture. Examples will be given of how MCS can be combined with modelling to improve drug development.

Moderator:
- Michael Leane, Associate Scientific Director, Bristol Myers Squibb - UK
- Tetsuya Ozeki, Chair for SIG on Drug Delivery and Manufacturing, International Pharmaceutical Federation (FIP) - Japan

Speaker:
- Kendal Pitt, Senior Technical Director, GlaxoSmithKline - UK
- Iris Ziegler, Director Pharmaceutical Sciences & QbD, Corden Pharma International GmbH - Germany
- Gavin Reynolds, Astra Zeneca - UK
- Neil Dawson, Senior Principal Scientist, Pfizer - UK

The ‘’FIP digital health in pharmacy education’’ report describes the readiness, adaptability, and responsiveness of pharmacy education to train current and future pharmaceutical workforce on digital health as well as knowledge and skill gaps of the pharmaceutical workforce to respond to the technological transformation. The launch event will showcase key findings from the ‘’FIP digital health in pharmacy education’’ survey, describe good practices on digital health education initiatives and a panel will be conducted to identify a roadmap for digital health education. Participants will have an opportunity to take part in a live simulation of a digital health education solution!

Learning Objectives:

- Learn about the key findings from the FIP Digital health in pharmacy education survey;

- Explore good practices on course descriptions, examples of assignments and learning activities on digital health,

- Identify areas of development for the long-term vision of digital health in pharmaceutical practice, science and education

The LLLP conferences bring together international and national colleagues with interest and research to share in the area of pharmacy education and professional development. The conference facilitates participant access to high quality educational programs, internationally significant research and development, and world-renowned leaders in the field.

A Forum on Human Resources for Health Supply Chain Management.

https://ptdevents.org.za/

Come to the 2020 FIP congress in Seville, Spain, where pharmacy practitioners, pharmaceutical scientists and educators from around the world will discuss and help you prepare for these new technologies that will empower our profession.

Previous industrial revolutions liberated humans from reliance on animal power, made mass production possible and brought digital capabilities to billions. This latest industrial revolution is, however, fundamentally different. It is characterised by a range of technologies that are fusing the physical, digital and biological worlds, impacting on all disciplines, economies and industries, and even challenging ideas about what it means to be human.

Digitalisation is already allowing the keeping of structured patient records, facilitating electronic prescribing, dispensing and administration of medicines, automating the handling of medicines in the supply chain, and providing tools for monitoring the efficacy and safety of medicines in use. Further advances will enable pharmacists to interact with patients through the creation of a common platform for accessing data and information in new, more efficient way.